{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:08:22Z","timestamp":1789715302124,"version":"4.0.1"},"reference-count":93,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["humanpathol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.humpath.2014.03.006","type":"journal-article","created":{"date-parts":[[2014,3,27]],"date-time":"2014-03-27T04:30:18Z","timestamp":1395894618000},"page":"1529-1540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Diagnostic utility of immunohistochemistry in distinguishing between epithelioid pleural mesotheliomas and breast carcinomas: a comparative study"],"prefix":"10.1016","volume":"45","author":[{"given":"Nelson G.","family":"Ord\u00f3\u00f1ez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysegul A.","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2014.03.006_bb0005","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0002-9343(77)90154-1","article-title":"Carcinomatous involvement of the pleura: an analysis of 96 patients","volume":"63","author":"Chernow","year":"1977","journal-title":"Am J Med"},{"key":"10.1016\/j.humpath.2014.03.006_bb0010","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1046\/j.1365-2559.2003.01674.x","article-title":"\u201cPseudomesotheliomatous\u201d carcinomas of the pleura: a 10-year analysis of cases from the Environmental Lung Disease Research Group, Cardiff","volume":"43","author":"Attanoos","year":"2003","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2014.03.006_bb0015","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1097\/00000478-199612000-00001","article-title":"Malignant vascular tumors of the serous membranes mimicking mesothelioma. A report of 14 cases","volume":"20","author":"Lin","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0020","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1097\/00000478-199712000-00016","article-title":"Malignant peripheral nerve sheath tumor of the pleura with epithelial and rhabdomyoblastic differentiation: report of a case clinically simulating mesothelioma","volume":"21","author":"Ord\u00f3\u00f1ez","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0025","first-page":"119","article-title":"Metastatic cystosarcoma phyllodes with pseudomesotheliomatous sarcomatosis of the contralateral pleura","volume":"9","author":"Hartmann","year":"1988","journal-title":"Pathologe"},{"key":"10.1016\/j.humpath.2014.03.006_bb0030","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1365-2559.2002.01422.x","article-title":"Primary thymic epithelial tumours of the pleura mimicking malignant mesothelioma","volume":"41","author":"Attanoos","year":"2002","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2014.03.006_bb0035","first-page":"534S","article-title":"Pleural \u201cpseudomesotheliomas\u201d\u2014a 10 year analysis (1990-2000)","volume":"18","author":"Attanoos","year":"2001","journal-title":"Eur Resp J"},{"key":"10.1016\/j.humpath.2014.03.006_bb0040","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1055\/s-2007-1020423","article-title":"Metastasis of cancer to cancer. A case of breast carcinoma metastasizing to a malignant mesothelioma","volume":"34","author":"Andersen","year":"1986","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1016\/j.humpath.2014.03.006_bb0045","doi-asserted-by":"crossref","first-page":"E80","DOI":"10.1177\/000313481007600706","article-title":"Maxillary sinus carcinoma metastases mimicking malignant pleural mesothelioma","volume":"76","author":"Erdem","year":"2010","journal-title":"Am Surg"},{"key":"10.1016\/j.humpath.2014.03.006_bb0050","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1365-2559.2011.03868.x","article-title":"The importance of retaining post mortem tissue\u2014\u201cpseudomesotheliomatous\u201d Merkel cell carcinoma of the pleura","volume":"58","author":"Leopold","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2014.03.006_bb0055","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1365-2559.2003.01685.x","article-title":"Synchronous diffuse malignant mesothelioma and carcinomas in asbestos-exposed individuals","volume":"43","author":"Attanoos","year":"2003","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2014.03.006_bb0060","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/00000478-200308000-00001","article-title":"The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma","volume":"27","author":"Ord\u00f3\u00f1ez","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0065","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/modpathol.3800544","article-title":"The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung: a comparative study","volume":"19","author":"Ord\u00f3\u00f1ez","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0070","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/modpathol.2013.34","article-title":"Value of PAX8, PAX2, napsin A, carbonic anhydrase IX, and claudin-4 immunostaining in distinguishing pleural epithelioid mesothelioma from metastatic renal cell carcinoma","volume":"26","author":"Ord\u00f3\u00f1ez","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0075","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/modpathol.2012.200","article-title":"Value of PAX8, PAX2, claudin-4, and h-caldesmon immunostaining in distinguishing peritoneal epithelioid mesotheliomas from serous carcinomas","volume":"26","author":"Ord\u00f3\u00f1ez","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0080","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/j.1365-2559.2011.04036.x","article-title":"Mesothelial markers in high-grade breast carcinoma","volume":"59","author":"Duhig","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2014.03.006_bb0085","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/j.1365-2559.2011.04031.x","article-title":"Expression of calretinin by breast carcinoma and the potential for misdiagnosis of mesothelioma","volume":"59","author":"Powell","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2014.03.006_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2012.05.014","article-title":"Application of immunohistochemistry in the diagnosis of epithelioid mesothelioma: a review and update","volume":"44","author":"Ord\u00f3\u00f1ez","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0095","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/modpathol.3800736","article-title":"D2-40 and calretinin\u2014a tissue microarray analysis of 341 malignant mesotheliomas with emphasis on sarcomatoid differentiation","volume":"20","author":"Hinterberger","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0100","doi-asserted-by":"crossref","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group","volume":"137","author":"Husain","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2014.03.006_bb0105","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/modpathol.2010.46","article-title":"The diagnostic utility of immunohistochemistry in distinguishing primary skin adnexal carcinomas from metastatic adenocarcinoma to skin: an immunohistochemical reappraisal using cytokeratin 15, nestin, p63, D2-40, and calretinin","volume":"23","author":"Mahalingam","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0110","doi-asserted-by":"crossref","DOI":"10.1097\/PAI.0b013e31829b6fbd","article-title":"Value of calretinin immunostaining in diagnostic pathology: a review and update","author":"Ord\u00f3\u00f1ez","year":"2013","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0115","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ijc.2910500308","article-title":"Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium","volume":"50","author":"Chang","year":"1992","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2014.03.006_bb0120","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/01.MP.0000056981.16578.C3","article-title":"Value of mesothelin immunostaining in the diagnosis of mesothelioma","volume":"16","author":"Ord\u00f3\u00f1ez","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0125","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0046-8177(03)00177-1","article-title":"Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas","volume":"34","author":"Frierson","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0130","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1097\/00000478-200311000-00003","article-title":"Application of mesothelin immunostaining in tumor diagnosis","volume":"27","author":"Ord\u00f3\u00f1ez","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0135","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.humpath.2003.11.013","article-title":"The diagnostic utility of immunohistochemistry in distinguishing between mesothelioma and renal cell carcinoma: a comparative study","volume":"35","author":"Ord\u00f3\u00f1ez","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0140","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s10549-012-2018-4","article-title":"Mesothelin, a novel immunotherapy target for triple negative breast cancer","volume":"133","author":"Tchou","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.humpath.2014.03.006_bb0145","article-title":"Value of podoplanin as an immunohistochemical marker in tumor diagnosis: a review and update","author":"Ord\u00f3\u00f1ez","year":"2013","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0150","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/modpathol.3800259","article-title":"Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma","volume":"18","author":"Chu","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0155","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.humpath.2005.01.019","article-title":"D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma","volume":"36","author":"Ord\u00f3\u00f1ez","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0160","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/01.pas.0000208280.29291.34","article-title":"D2-40 is not a specific marker for cells of mesothelial origin in serous effusions","volume":"30","author":"Bassarova","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0165","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/PAI.0b013e3181e9fe74","article-title":"Podoplanin immunostaining in cutaneous apocrine carcinoma and in cutaneous metastasis from the breast","volume":"18","author":"Fernandez-Flores","year":"2010","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0170","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/00000478-199712000-00003","article-title":"The immunohistochemical diagnostic panel for epithelial mesothelioma: a reevaluation after heat-induced epitope retrieval","volume":"21","author":"Riera","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0175","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/ajcp\/110.3.385","article-title":"Thrombomodulin expression in transitional cell carcinoma","volume":"110","author":"Ord\u00f3\u00f1ez","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0180","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/modpathol.3880018","article-title":"Value of the mesothelium-associated antibodies thrombomodulin, cytokeratin 5\/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura","volume":"13","author":"Cury","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0185","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/00000478-200004000-00016","article-title":"Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma","volume":"24","author":"Ord\u00f3\u00f1ez","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0190","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1440-1827.2007.02080.x","article-title":"Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma","volume":"57","author":"Kushitani","year":"2007","journal-title":"Pathol Int"},{"key":"10.1016\/j.humpath.2014.03.006_bb0195","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00129039-200406000-00004","article-title":"Wilms tumor gene product: sensitive and contextually specific marker of serous carcinomas of ovarian surface epithelial origin","volume":"12","author":"Hwang","year":"2004","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0200","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/dc.20643","article-title":"WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions","volume":"35","author":"Zhu","year":"2007","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0205","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1097\/PAS.0b013e31816d71ad","article-title":"Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas","volume":"32","author":"Nonaka","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0210","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3109\/00313025.2010.508793","article-title":"Differential diagnosis of serous papillary carcinoma of the gynaecological tract and basal breast carcinoma: an immunohistochemical approach","volume":"42","author":"Armes","year":"2010","journal-title":"Pathology"},{"key":"10.1016\/j.humpath.2014.03.006_bb0215","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00428-007-0448-x","article-title":"Claudin 4 identifies a wide spectrum of epithelial neoplasms and represents a very useful marker for carcinoma versus mesothelioma diagnosis in pleural and peritoneal biopsies and effusions","volume":"451","author":"Facchetti","year":"2007","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2014.03.006_bb0220","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1309\/AJCP0B3YJBXWXJII","article-title":"Value of claudin-4 immunostaining in the diagnosis of mesothelioma","volume":"139","author":"Ord\u00f3\u00f1ez","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0225","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/jcp.2005.028589","article-title":"Claudins in differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleura","volume":"59","author":"Soini","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0230","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/jcp.48.7.626","article-title":"OV 632 and MOC 31 in the diagnosis of mesothelioma and adenocarcinoma: an assessment of their use in formalin-fixed and paraffin wax embedded material","volume":"48","author":"Edwards","year":"1995","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0235","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0046-8177(98)90227-1","article-title":"Value of the MOC-31 monoclonal antibody in differentiating epithelial pleural mesothelioma from lung adenocarcinoma","volume":"29","author":"Ord\u00f3\u00f1ez","year":"1998","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0240","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1309\/8FCHQ3VPBWM7B5X9","article-title":"Immunohistochemical analysis of peritoneal mesothelioma and primary and secondary serous carcinoma of the peritoneum: antibodies to estrogen and progesterone receptors are useful","volume":"125","author":"Barnetson","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0245","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/ajcp\/109.1.85","article-title":"Value of the Ber-EP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma. The M.D. Anderson experience and a critical review of the literature","volume":"109","author":"Ord\u00f3\u00f1ez","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0250","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1097\/00000478-199712000-00002","article-title":"The value of antibodies 44-3A6, SM3, HBME-1, and thrombomodulin in differentiating epithelial pleural mesothelioma from lung adenocarcinoma: a comparative study with other commonly used antibodies","volume":"21","author":"Ord\u00f3\u00f1ez","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0255","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1053\/hupa.2001.24329","article-title":"Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma","volume":"32","author":"Comin","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0260","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/modpathol.3800471","article-title":"The diagnostic utility of immunohistochemistry and electron microscopy in distinguishing between peritoneal mesotheliomas and serous carcinomas: a comparative study","volume":"19","author":"Ord\u00f3\u00f1ez","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0265","first-page":"342","article-title":"Diagnosis of diffuse malignant mesothelioma: experience of a US\/Canadian Mesothelioma Panel","volume":"4","author":"McCaughey","year":"1991","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0270","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/00000478-200105000-00007","article-title":"Calretinin and other mesothelioma markers in synovial sarcoma: analysis of antigenic similarities and differences with malignant mesothelioma","volume":"25","author":"Miettinen","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0275","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0046-8177(89)90137-8","article-title":"Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin","volume":"20","author":"Wick","year":"1989","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0280","first-page":"158","article-title":"Gross cystic disease fluid protein-15 in salivary gland tumors","volume":"115","author":"Swanson","year":"1991","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2014.03.006_bb0285","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00000372-199506000-00006","article-title":"An immunohistochemical study of lysozyme, CD-15 (Leu M1), and gross cystic disease fluid protein-15 in various skin tumors. Assessment of the specificity and sensitivity of markers of apocrine differentiation","volume":"17","author":"Ansai","year":"1995","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0290","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0046-8177(97)90009-5","article-title":"Metastatic adenocarcinoma to the brain: an immunohistochemical approach","volume":"28","author":"Perry","year":"1997","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0295","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/PAS.0b013e318157a5a6","article-title":"Gross cystic disease fluid protein-(GCDFP-15): expression in primary lung adenocarcinoma","volume":"32","author":"Striebel","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0300","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/modpathol.2010.38","article-title":"A study of immunohistochemical differential expression in pulmonary and mammary carcinomas","volume":"23","author":"Yang","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0305","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1097\/01.pas.0000176429.88702.36","article-title":"Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary","volume":"29","author":"Tornos","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0310","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1309\/TDP92PQLDE2HLEET","article-title":"Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity","volume":"127","author":"Bhargava","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0315","first-page":"1221","article-title":"Co-expression and prognostic value of gross cystic disease fluid protein 15 and mammaglobin in primary breast cancer","volume":"22","author":"Fritzsche","year":"2007","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0320","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.humpath.2012.10.009","article-title":"Expression of mammaglobin and gross cystic disease fluid protein-15 in breast carcinomas","volume":"44","author":"Luo","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0325","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1309\/AJCPMFR6OA8ICHNH","article-title":"Relationship between molecular subtype of invasive breast carcinoma and expression of gross cystic disease fluid protein 15 and mammaglobin","volume":"135","author":"Lewis","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0330","first-page":"238","article-title":"Immunohistochemical characteristics of triple negative\/basal-like breast cancer","volume":"28","author":"Pala","year":"2012","journal-title":"Turk Patoloji Derg"},{"key":"10.1016\/j.humpath.2014.03.006_bb0335","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2559.2012.04344.x","article-title":"Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer","volume":"62","author":"Huo","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2014.03.006_bb0340","doi-asserted-by":"crossref","first-page":"239","DOI":"10.5858\/2008-132-239-AOEPOB","article-title":"Analysis of expression patterns of breast cancer-specific markers (mammaglobin and gross cystic disease fluid protein 15) in lung and pleural tumors","volume":"132","author":"Takeda","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2014.03.006_bb0345","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/BF03349687","article-title":"Uteroglobin and uteroglobin-like proteins: the uteroglobin family of proteins","volume":"17","author":"Miele","year":"1994","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.humpath.2014.03.006_bb0350","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.5858\/2003-127-1330-MEILNI","article-title":"Mammaglobin expression in lymph nodes is an important marker of metastatic breast carcinoma","volume":"127","author":"Han","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2014.03.006_bb0355","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/modpathol.3800731","article-title":"Breast-specific expression of MGB1\/mammaglobin: an examination of 480 tumors from various organs and clinicopathological analysis of MGB1-positive breast cancers","volume":"20","author":"Sasaki","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0360","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/cncr.20627","article-title":"Mammaglobin and CRxA-01 in pleural effusion cytology: potential utility of distinguishing metastatic breast carcinomas from other cytokeratin 7\u2013positive\/cytokeratin 20\u2013negative carcinomas","volume":"102","author":"Ciampa","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2014.03.006_bb0365","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/dc.21039","article-title":"Diagnostic utility of mammaglobin and GCDFP-15 in the identification of metastatic breast carcinoma in fluid specimens","volume":"37","author":"Yan","year":"2009","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0370","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ncb1530","article-title":"Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation","volume":"9","author":"Asselin-Labat","year":"2007","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0375","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/PAP.0b013e3182a28a68","article-title":"Value of GATA3 immunostaining in tumor diagnosis: a review","volume":"20","author":"Ord\u00f3\u00f1ez","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0380","first-page":"352","article-title":"Value of GATA3 immunostaining in the diagnosis of parathyroid tumors","volume":"20","author":"Ord\u00f3\u00f1ez","year":"2013","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0385","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","article-title":"GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors","volume":"38","author":"Miettinen","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0390","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jamcollsurg.2004.12.025","article-title":"GATA-3 expression as a predictor of hormone response in breast cancer","volume":"200","author":"Parikh","year":"2005","journal-title":"J Am Coll Surg"},{"issue":"Suppl 2","key":"10.1016\/j.humpath.2014.03.006_bb0395","first-page":"32A","article-title":"GATA3 expression and relationship between clinicopathological parameters in invasive breast carcinomas (abstract)","volume":"26","author":"Cakir","year":"2013","journal-title":"Mod Pathol"},{"issue":"Suppl 2","key":"10.1016\/j.humpath.2014.03.006_bb0400","first-page":"36A","article-title":"GATA3 expression in different subtypes of invasive breast carcinoma and comparison with GCDFP15 and mammaglobin (abstract)","volume":"26","author":"Deftereos","year":"2013","journal-title":"Mod Pathol"},{"issue":"Suppl 2","key":"10.1016\/j.humpath.2014.03.006_bb0405","first-page":"213A","article-title":"The role of GATA3 in the differential diagnosis of upper tract urothelial and collecting duct carcinomas (abstract)","volume":"26","author":"Gonzalez-Roibon","year":"2013","journal-title":"Mod Pathol"},{"issue":"Suppl 2","key":"10.1016\/j.humpath.2014.03.006_bb0410","first-page":"71A","article-title":"Significance of GATA3 expression in outcomes of breast cancer patients who received systemic chemo and\/or hormonal therapy and clinicopathological features of GATA3 positive tumors (abstract)","volume":"26","author":"Surowiecka","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0415","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.humpath.2012.11.003","article-title":"GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas","volume":"44","author":"Cimino-Mathews","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0420","doi-asserted-by":"crossref","first-page":"R40","DOI":"10.1186\/bcr2327","article-title":"Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours","volume":"11","author":"Albergaria","year":"2009","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.humpath.2014.03.006_bb0425","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.humpath.2012.09.010","article-title":"GATA-3 expression in male and female breast cancers: comparison of clinicopathologic parameters and prognostic relevance","volume":"44","author":"Gonzalez","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0430","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/(SICI)1097-0215(19990420)84:2<122::AID-IJC5>3.0.CO;2-S","article-title":"GATA-3 is expressed in association with estrogen receptor in breast cancer","volume":"84","author":"Hoch","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2014.03.006_bb0435","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.humpath.2008.09.010","article-title":"The significance of GATA3 expression in breast cancer: a 10-year follow-up study","volume":"40","author":"Ciocca","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0440","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.humpath.2010.06.010","article-title":"Higher levels of GATA3 predict better survival in women with breast cancer","volume":"41","author":"Yoon","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0445","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.humpath.2005.08.008","article-title":"Value of estrogen and progesterone receptor immunostaining in distinguishing between peritoneal mesotheliomas and serous carcinomas","volume":"36","author":"Ord\u00f3\u00f1ez","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0450","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/PAP.0b013e31823e472e","article-title":"Napsin A, expression in lung and kidney neoplasia: a review and update","volume":"19","author":"Ord\u00f3\u00f1ez","year":"2012","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0455","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/PAI.0b013e31825439bc","article-title":"Value of thyroid transcription factor-1 immunostaining in tumor diagnosis: a review and update","volume":"20","author":"Ord\u00f3\u00f1ez","year":"2012","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0460","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/PAP.0b013e318253465d","article-title":"Value of PAX 8 immunostaining in tumor diagnosis: a review and update","volume":"19","author":"Ord\u00f3\u00f1ez","year":"2012","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.humpath.2014.03.006_bb0465","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/PAP.0b013e318271a382","article-title":"Value of PAX2 immunostaining in tumor diagnosis: a review and update","volume":"19","author":"Ord\u00f3\u00f1ez","year":"2012","journal-title":"Adv Anat Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817714001233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817714001233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T02:41:05Z","timestamp":1648694465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817714001233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":93,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0046817714001233"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2014.03.006","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic utility of immunohistochemistry in distinguishing between epithelioid pleural mesotheliomas and breast carcinomas: a comparative study","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2014.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}